Grossesse et allaitement : guide thérapeutique. CHU sainte Justine, Québec : Broché. 2007. adverse birth outcomes following gestional exposure to statins, Am J Med Genet, vol.131, pp.287-298, 2004. ,
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.33, issue.11, pp.888-96, 2005. ,
DOI : 10.1002/bdra.20181
Troisième édition, pp.498-509, 2009. ,
Etude nationale nutrition et santé, 2006. ,
Structure et métabolisme des lipoprotéines. Biochimie hématologie. 3ème édition. Collection le moniteur internat, pp.173-96 ,
Hypertriglyc??rid??mies gestationnelles s??v??res??: complications et principes de prise en charge, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.37, issue.5, pp.517-537, 2008. ,
DOI : 10.1016/j.jgyn.2007.12.007
Troubles du métabolisme des lipides. Pathologies maternelles et grossesse. MEDSI/MC grow hill, pp.180-86 ,
Sang Thrombose Vaisseaux, pp.635-676, 1996. ,
Prolonged inadvertent pravastatine use in pregnancy, J reprotox, vol.11, p.3, 2003. ,
Les effets pléiotropes des statines, Forum Med Suisse, vol.8, issue.10, pp.187-90, 2008. ,
Maternal exposure to statins and risk for birth defects: A case-series approach, American Journal of Medical Genetics Part A, vol.116, issue.20, pp.2701-2706, 2008. ,
DOI : 10.1002/ajmg.a.32493
Risk of congenital anomalies in pregnant users of statin drugs, British Journal of Clinical Pharmacology, vol.142, issue.4, pp.496-509, 2007. ,
DOI : 10.1067/mob.2003.223
Pregnancies outcome after medication with HMG CoA Reductase inhibitors in the First trimester. Reprod Toxicology (abs), pp.254-55, 2004. ,
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study, BJOG: An International Journal of Obstetrics & Gynaecology, vol.21, issue.Suppl 4, 2010. ,
DOI : 10.1111/1471-0528.12066
Prenatal exposure to HMG-CoA reductase inhibitors: Effects on fetal and neonatal outcomes, Reproductive Toxicology, vol.26, issue.2, pp.175-182, 2008. ,
DOI : 10.1016/j.reprotox.2008.06.009
Atorvastatine Drugs in Pregnancy and Lactation: A reference Guide to Fetal and Neonatal Risk, pp.106-113, 2008. ,
Drugs in Pregnancy and Lactation: A reference Guide to Fetal and Neonatal Risk, pp.1146-1153, 2008. ,
Drugs in Pregnancy and Lactation: A reference Guide to Fetal and Neonatal Risk, pp.578-587, 2008. ,
Simvastatine Drugs in Pregnancy and Lactation: A reference Guide to Fetal and Neonatal Risk, pp.1258-60, 2008. ,
Introduction. Drugs in Pregnancy and Lactation: A reference Guide to Fetal and Neonatal Risk, 2008. ,
Pre- and Postnatal Toxicity of the HMG-CoA Reductase Inhibitor Atorvastatin in Rats, Toxicological Sciences, vol.41, issue.1, pp.88-99, 1998. ,
DOI : 10.1093/toxsci/41.1.88
Risks of statin use during pregnancy : a systématic review, JOGC, pp.906-914, 2007. ,
Use of lipid-lowering agents (statins) during pregnancy, 2010. ,
Preliminary data on exposure to statins during pregnancy, Reprod Toxicol, vol.20, issue.3, pp.471-472, 2005. ,
Prevention of fluvastatin-induced toxicity, mortality, and cardiac myopathy in pregnant rats by mevalonic acid supplementation, Teratology, vol.11, issue.1, pp.19-26, 1994. ,
DOI : 10.1002/tera.1420500104
Fluvastatin exposure during pregnancy, Obstet Gynecol, vol.93, p.847, 1999. ,
DOI : 10.1097/00006250-199905001-00026
Congenital abnormalities (VATER) in baby born to mother using lovastatin, The Lancet, vol.339, issue.8806, p.1416, 1992. ,
DOI : 10.1016/0140-6736(92)91237-3
Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy, Reproductive Toxicology, vol.10, issue.6, pp.439-485, 1996. ,
DOI : 10.1016/S0890-6238(96)00130-X
Prolonged inadvertent pravastatin use in pregnancy, Reproductive Toxicology, vol.18, issue.2, pp.299-300, 2004. ,
DOI : 10.1016/j.reprotox.2003.11.003
Simvastatine et grossesse, Therapie, vol.51, pp.537-579, 1996. ,
Reproduction studies of bezafibrate (2nd report) -teratological study in rats, Kiso to Rinsho, vol.22, p.4415, 1988. ,
Teratological and prenatal toxicity evaluations of a new hypolipemic agent. (abs), Teratology, vol.14, p.376, 1976. ,
Teratological study of orally administered fenofibrate in rats, Chiryo, 1995. ,
Drugs in Pregnancy and Lactation: A reference Guide to Fetal and Neonatal Risk, pp.613-617, 2008. ,
Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase, Clinical Biochemistry, vol.35, issue.2, pp.125-155, 2002. ,
DOI : 10.1016/S0009-9120(02)00283-7
Anti-cholesterol agent pregnancy exposure outcomes, Reproductive Toxicology, vol.8, issue.5, pp.445-451, 1994. ,
DOI : 10.1016/0890-6238(94)90091-4
Eruptive xanthomas during pregnancy, Journal of the American Academy of Dermatology, vol.27, issue.2, pp.300-302, 1992. ,
DOI : 10.1016/0190-9622(92)70185-I
Successful pregnancy in a woman with lipoatrophic diabetes mellitus. A case report, J Reprod Med, vol.45, pp.850-852, 2000. ,
Situs Inversus, Encephalocele and Jejunal Atresia Following Exposure to Gemfibrozil in Pregnancy, Paediatrics & Child Health, vol.7, issue.suppl_A, p.54, 2002. ,
DOI : 10.1093/pch/7.suppl_A.55Ac
Reproductive studies on cholestyramine, Kiso to Rinsho, vol.16, 1982. ,
Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy, BJOG: An International Journal of Obstetrics and Gynaecology, vol.99, issue.2, pp.169-70, 1995. ,
DOI : 10.1111/j.1471-0528.1995.tb09077.x
Anti-cholesterol agent pregnancy exposure outcomes, Reproductive Toxicology, vol.8, issue.5, pp.445-446, 1994. ,
DOI : 10.1016/0890-6238(94)90091-4
Oméga 3. www.micromedex.com, 2010. ,
Oméga 3. www.micromedex.com, 2010. ,
Embryologie humaine, deuxième édition édition, Boeck, 2003. ,